Expert Opinion on Pharmacotherapy

Calcium, vitamin D supplements with or without alendronate and supragingival calculus formation in osteoporotic women: a preliminary study
pp. 2015-2020(6)
Authors: Buduneli, Nurcan; Saygan, Buket Han; Karaduman, Ural; Saraç, Fulden; Karaduman, Musa; Ayçelik, Necmettin

Influence of food on the pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor
pp. 2021-2025(5)
Authors: Holdich, Tom; Sawyer, James

Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors
pp. 2027-2038(12)
Authors: Huber, Christian G; Naber, Dieter; Lambert, Martin

Management of incomplete remission and treatment resistance in first-episode psychosis
pp. 2039-2051(13)
Authors: Lambert, Martin; Naber, Dieter; Huber, Christian G

Child and adolescent schizophrenia: pharmacological approaches
pp. 2053-2068(16)
Authors: Madaan, Vishal; Dvir, Yael; Wilson, Daniel R

The risk of stroke within a week of minor stroke or transient ischemic attack
pp. 2069-2076(8)
Authors: Sanossian, Nerses; Ovbiagele, Bruce

Emerging therapeutic regimes for the management of mycetomas
pp. 2077-2085(9)
Authors: Ameen, Mahreen; Arenas, Roberto

Treatment strategies in CNS metastases
pp. 2087-2098(12)
Authors: Kosmas, Christos; Tsakonas, George; Mylonakis, Nikolaos

Pharmacotherapy of lupus nephritis: time for a consensus?
pp. 2099-2115(17)
Authors: Perysinaki, Garyfallia; Panagiotakis, Simeon; Bertsias, George; Boumpas, Dimitrios T

Treatment strategies for amyloid A amyloidosis
pp. 2117-2128(12)
Authors: Pettersson, T; Konttinen, YT; Maury, CPJ

Desvenlafaxine succinate for the treatment of major depressive disorder
pp. 2129-2136(8)
Authors: Lohoff, Falk W; Rickels, Karl

Acadesine, an adenosine-regulating agent with the potential for widespread indications
pp. 2137-2144(8)
Authors: Drew, Brian G; Kingwell, Bronwyn A

Rosuvastatin: efficacy, safety and clinical effectiveness
pp. 2145-2160(16)
Authors: Soran, Handrean; Durrington, Paul

Sibutramine: current status as an anti-obesity drug and its future perspectives
pp. 2161-2173(13)
Authors: Sharma, Bikash; Henderson, David C

Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?
pp. 2175-2180(6)
Authors: Manenti, Lucio; Tansinda, Pius; Vaglio, Augusto

An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update)
pp. 2181-2195(15)
Author: Philis-Tsimikas, Athena

A new lipoglycopeptide: telavancin
pp. 2197-2207(11)
Authors: Nannini, Esteban C; Stryjewski, Martin E

Update on tizanidine for muscle spasticity and emerging indications
pp. 2209-2215(7)
Authors: Malanga, Gerard; Reiter, Raymond D; Garay, Edward